Skip to content
10-Q

Quarterly Report

VASCULAR SOLUTIONS INC

0001140361-15-038094

← back to feed
Filed
Oct 20, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Oct 19, 2015 17.34M sh
Stockholders Equity Q3 2015 · Sep 30, 2015 $124.62M
Stockholders Equity Q3 2015 · Dec 31, 2014 $113.34M
Current Liabilities Q3 2015 · Sep 30, 2015 $17.65M
Current Liabilities Q3 2015 · Dec 31, 2014 $13.02M
Current Assets Q3 2015 · Sep 30, 2015 $88.47M
Current Assets Q3 2015 · Dec 31, 2014 $78.39M
Total Assets Q3 2015 · Sep 30, 2015 $143.14M
Total Assets Q3 2015 · Dec 31, 2014 $127.37M
Shares Diluted Q3 2015 · Sep 30, 2014 17.69M sh
Shares Diluted Q3 2015 · Sep 30, 2014 17.64M sh
Stock Repurchased Q3 2015 · Sep 30, 2014 $2.31M
Capex Q3 2015 · Sep 30, 2014 $3.83M
Cash And Equivalents Q3 2015 · Sep 30, 2014 $41.65M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $30.79M
Eps Diluted Q3 2015 · Sep 30, 2014 $0.15
Eps Diluted Q3 2015 · Sep 30, 2014 $0.49
Eps Basic Q3 2015 · Sep 30, 2014 $0.15
Eps Basic Q3 2015 · Sep 30, 2014 $0.51
Sga Expense Q3 2015 · Sep 30, 2014 $3.69M
Sga Expense Q3 2015 · Sep 30, 2014 $9.28M
Rd Expense Q3 2015 · Sep 30, 2014 $3.32M
Rd Expense Q3 2015 · Sep 30, 2014 $9.84M
Net Income Q3 2015 · Sep 30, 2014 $2.57M
Net Income Q3 2015 · Sep 30, 2014 $8.57M
Operating Income Q3 2015 · Sep 30, 2014 $5.21M
Operating Income Q3 2015 · Sep 30, 2014 $14.62M
Cost Of Revenue Q3 2015 · Sep 30, 2014 $10.29M
Cost Of Revenue Q3 2015 · Sep 30, 2014 $30.16M
Revenue Q3 2015 · Sep 30, 2014 $31.93M
Revenue Q3 2015 · Sep 30, 2014 $92.51M